Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID

10673575

Project number

272201300018I-P00008-759301900132-1

Recipient

EMORY UNIVERSITY

Principal Investigator

Mark Joseph Mulligan

Activity code

N01

Funding institute

NIH

Fiscal year

2022

Award amount

$106,523

Award type

—

Project period

2019-07-12 → 2023-11-30